Peter Altman's most recent trade in BioCardia Inc. was a trade of 300 shares done at an average price of $1.0 . Disclosure was reported to the exchange on Oct. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 15 Oct 2026 | 300 | 385,385 (5%) | 0% | 1.0 | 285 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 15 Oct 2026 | 200 | 385,085 (5%) | 0% | 1.0 | 190 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 29 Sep 2026 | 1,000 | 384,885 (5%) | 0% | 1.0 | 1,030 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 23 Sep 2026 | 1,900 | 383,885 (5%) | 0% | 1.1 | 1,995 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 03 Sep 2026 | 800 | 381,985 (5%) | 0% | 1.1 | 872 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.93 per share. | 17 Aug 2026 | 5,400 | 381,115 (5%) | 0% | 0.9 | 5,022 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.92 per share. | 13 Aug 2026 | 1,900 | 375,785 (5%) | 0% | 0.9 | 1,748 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 29 Jul 2026 | 5,000 | 373,885 (5%) | 0% | 0.8 | 3,900 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 17 Jul 2026 | 500 | 368,885 (5%) | 0% | 0.8 | 415 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 14 Jul 2026 | 2,800 | 366,885 (5%) | 0% | 0.9 | 2,464 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 14 Jul 2026 | 1,500 | 368,385 (5%) | 0% | 0.9 | 1,290 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 08 Jul 2026 | 5,500 | 367,485 (5%) | 0% | 1.0 | 5,335 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jul 2026 | 5,400 | 361,985 (5%) | 0% | 1.0 | 5,208 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.94 per share. | 08 Jul 2026 | 1,000 | 369,485 (5%) | 0% | 0.9 | 940 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 08 Jul 2026 | 1,000 | 368,485 (5%) | 0% | 0.9 | 900 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | 02 Jul 2026 | 57,688 | 147,903 | - | - | Stock Option (right to buy) | ||
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.24 per share. | 02 Jul 2026 | 54,606 | 356,585 (5%) | 0% | 1.2 | 67,711 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.20 per share. | 29 Jun 2026 | 110,625 | 411,191 (6%) | 1% | 1.2 | 132,750 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 17 Jun 2026 | 1,500 | 299,766 (4%) | 0% | 0.9 | 1,275 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 17 Jun 2026 | 800 | 300,566 (4%) | 0% | 1.0 | 768 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 09 Jun 2026 | 5,000 | 298,266 (4%) | 0% | 0.9 | 4,250 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.92 per share. | 19 May 2026 | 1,500 | 293,266 (4%) | 0% | 0.9 | 1,380 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 19 May 2026 | 200 | 291,766 (4%) | 0% | 1.0 | 190 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.92 per share. | 18 May 2026 | 5,700 | 291,566 (4%) | 0% | 0.9 | 5,244 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 15 May 2026 | 5,100 | 285,866 (4%) | 0% | 1.0 | 5,202 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 29 Apr 2026 | 5,000 | 280,766 (4%) | 0% | 1.1 | 5,550 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 20 Apr 2026 | 600 | 275,366 (4%) | 0% | 1.2 | 738 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 20 Apr 2026 | 600 | 275,366 (4%) | 0% | 1.2 | 738 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 20 Apr 2026 | 400 | 275,766 (4%) | 0% | 1.2 | 492 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 20 Apr 2026 | 400 | 275,766 (4%) | 0% | 1.2 | 492 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.24 per share. | 24 Mar 2026 | 600 | 274,466 (4%) | 0% | 1.2 | 744 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.24 per share. | 24 Mar 2026 | 600 | 274,466 (4%) | 0% | 1.2 | 744 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 24 Mar 2026 | 300 | 274,766 (4%) | 0% | 1.2 | 366 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 24 Mar 2026 | 300 | 274,766 (4%) | 0% | 1.2 | 366 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 04 Feb 2026 | 5,000 | 273,866 (4%) | 0% | 1.1 | 5,650 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 04 Feb 2026 | 5,000 | 273,866 (4%) | 0% | 1.1 | 5,650 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 16 Dec 2025 | 900 | 267,966 (3%) | 0% | 1.3 | 1,170 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 16 Dec 2025 | 200 | 267,066 (3%) | 0% | 1.4 | 274 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.37 per share. | 08 Dec 2025 | 106,588 | 323,350 (4%) | 1% | 1.4 | 146,026 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.37 per share. | 08 Dec 2025 | 56,484 | 266,866 (3%) | 0% | 1.4 | 77,383 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | 08 Dec 2025 | 38,000 | 90,215 | - | - | Stock Option (right to buy) | ||
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | 19 Sep 2025 | 48,000 | 143,612 | - | - | Warrant (right to buy) | ||
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 19 Sep 2025 | 48,000 | 216,762 (3%) | 0% | 1.3 | 60,000 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.83 per share. | 22 Aug 2025 | 700 | 168,762 (2%) | 0% | 1.8 | 1,281 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.83 per share. | 13 Aug 2025 | 100 | 168,062 (2%) | 0% | 1.8 | 183 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 12 Aug 2025 | 400 | 167,962 (2%) | 0% | 1.8 | 700 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 11 Aug 2025 | 1,700 | 167,562 (2%) | 0% | 1.8 | 2,989 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 30 Jun 2025 | 24,096 | 165,862 (2%) | 0% | 2.1 | 49,999 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | 30 Jun 2025 | 24,096 | 95,612 | - | - | Warrant (right to buy) | ||
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 30 May 2025 | 100 | 141,766 (2%) | 0% | 2.2 | 221 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 20 May 2025 | 1,600 | 140,966 (2%) | 0% | 2.1 | 3,328 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.89 per share. | 20 May 2025 | 700 | 141,666 (2%) | 0% | 1.9 | 1,323 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.43 per share. | 14 May 2025 | 300 | 139,366 (2%) | 0% | 2.4 | 730 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 14 May 2025 | 100 | 139,066 (2%) | 0% | 3.0 | 299 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 23 Apr 2025 | 26,246 | 138,966 (2%) | 0% | 1.9 | 49,999 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | 23 Apr 2025 | 26,246 | 71,516 | - | - | Warrant (right to buy) | ||
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 15 Apr 2025 | 100 | 112,720 (1%) | 0% | 2.1 | 214 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.99 per share. | 10 Apr 2025 | 300 | 112,320 (1%) | 0% | 2.0 | 597 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 10 Apr 2025 | 300 | 112,620 (1%) | 0% | 2.0 | 609 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.96 per share. | 07 Apr 2025 | 500 | 112,020 (1%) | 0% | 2.0 | 980 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 04 Apr 2025 | 800 | 111,520 (1%) | 0% | 2.0 | 1,632 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 03 Apr 2025 | 1,200 | 109,620 (1%) | 0% | 2.2 | 2,688 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 02 Apr 2025 | 600 | 110,720 (1%) | 0% | 2.2 | 1,320 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.23 per share. | 02 Apr 2025 | 500 | 110,120 (1%) | 0% | 2.2 | 1,115 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 03 Mar 2025 | 500 | 108,420 (1%) | 0% | 2.1 | 1,055 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.48 per share. | 07 Feb 2025 | 600 | 107,920 (1%) | 0% | 2.5 | 1,488 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 29 Jan 2025 | 500 | 107,081 (1%) | 0% | 2.4 | 1,200 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 29 Jan 2025 | 239 | 107,320 (1%) | 0% | 2.4 | 569 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 23 Dec 2024 | 1,000 | 106,581 (1%) | 0% | 2.1 | 2,060 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 05 Dec 2024 | 250 | 105,581 (1%) | 0% | 2.2 | 555 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 15 Nov 2024 | 1,350 | 105,331 (1%) | 0% | 1.9 | 2,525 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.65 per share. | 11 Oct 2024 | 44,250 | 125,661 (1%) | 0% | 2.7 | 117,263 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 11 Oct 2024 | 21,680 | 103,981 (1%) | 0% | 2.7 | 57,452 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 03 Sep 2024 | 41,666 | 81,411 (1%) | 0% | 3 | 124,998 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | 03 Sep 2024 | 41,666 | 41,666 | - | - | Warrant (right to buy) | ||
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 28 Jun 2024 | 300 | 39,745 (0%) | 0% | 3.1 | 915 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 28 Jun 2024 | 200 | 39,445 (0%) | 0% | 3.0 | 598 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.29 per share. | 21 Jun 2024 | 500 | 39,245 (0%) | 0% | 3.3 | 1,645 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.52 per share. | 14 Jun 2024 | 500 | 38,745 (0%) | 0% | 3.5 | 1,760 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.36 per share. | 10 Jun 2024 | 1,000 | 38,245 (0%) | 0% | 3.4 | 3,360 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 19 Apr 2024 | 2,750 | 558,697 (8%) | 0% | 0.4 | 1,013 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 28 Mar 2024 | 500 | 555,947 (8%) | 0% | 0.4 | 195 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.46 per share. | 13 Feb 2024 | 108,108 | 555,447 (8%) | 1% | 0.5 | 50,000 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | 13 Feb 2024 | 54,054 | 121,538 | - | - | Warrant (right to buy | ||
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 17 Aug 2023 | 4,000 | 447,339 (6%) | 0% | 0.9 | 3,484 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.87 per share. | 17 Aug 2023 | 4,000 | 447,339 (6%) | 0% | 0.9 | 3,484 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 14 Aug 2023 | 4,500 | 443,339 (6%) | 0% | 0.9 | 3,978 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.88 per share. | 14 Aug 2023 | 4,500 | 443,339 (6%) | 0% | 0.9 | 3,978 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.34 per share. | 23 Jun 2023 | 6,421 | 438,839 (6%) | 0% | 2.3 | 14,999 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.77 per share. | 31 May 2023 | 36,821 | 432,418 (6%) | 0% | 1.8 | 65,173 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 26 May 2023 | 6,200 | 469,239 (6%) | 0% | 1.6 | 9,920 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | 18 May 2023 | 159,723 | 159,723 | - | - | Stock Option (right to buy) | ||
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 18 May 2023 | 109,324 | 463,039 (6%) | 1% | 1.7 | 185,851 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.68 per share. | 16 Dec 2022 | 14,880 | 347,827 (5%) | 0% | 1.7 | 24,998 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 10 Nov 2022 | 3,100 | 331,547 (4%) | 0% | 1.9 | 5,797 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 10 Nov 2022 | 1,400 | 332,947 (4%) | 0% | 1.9 | 2,604 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.81 per share. | 22 Sep 2022 | 3,100 | 327,047 (4%) | 0% | 1.8 | 5,611 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 22 Sep 2022 | 1,400 | 328,447 (4%) | 0% | 1.9 | 2,618 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.92 per share. | 21 Sep 2022 | 2,750 | 323,947 (4%) | 0% | 1.9 | 5,280 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.46 per share. | 10 Jun 2022 | 4,500 | 321,197 (4%) | 0% | 1.5 | 6,570 | Common Stock |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 12 May 2022 | 31,446 | 316,697 (4%) | 0% | 1.3 | 41,509 | Common Stock |